Atomoxetine Ameliorates Nocturnal Enuresis with Subclinical Attention-Deficit / Hyperactivity Disorder (ADHD).
Pediatr Int. 2016 Aug 8;
Authors: Ohtomo Y
Abstract
BACKGROUND: Recent studies showed that incontinence and ADHD co-exist and interact each other. However, the treatment for the patients with nocturnal enuresis (NE) and ADHD has not been established.
METHODS: At the first visits to the outpatient clinic, we routinely performed the careful physical examination and history taking in 265 new patients with NE. After having been excluded the possibility of comorbid ADHD and related disorders, patients with MNE (monosymptomatic NE) were treated with desmopressin and/or alarm and those with NMNE (non-monosymptomatic NE) were treated with anti-cholinergics and/or alarm. These treatments for 12 weeks did not work in 65 patients and we re-assessed whether they had comorbid ADHD, and 24 met the diagnostic criteria. They were treated with atomoxetine (1.8mg /kg/day) in addition to ongoing therapy for enuresis.
RESULTS: After 8 weeks atomoxetine therapy, the average wet nights per months were significantly decreased: 18.5 to 4.6 in MNE (p=0.001) and 22.1 to 12.4 in NMNE (p=0.0251). Overall, atomoxetine treatment was beneficial in 19 of 24 cases.
CONCLUSIONS: Our clinical experience support the use of atomoxetine may be one of the options for refractory NE with comorbid ADHD. This article is protected by copyright. All rights reserved.
PMID: 27501068 [PubMed – as supplied by publisher]
via http://www.ncbi.nlm.nih.gov/pubmed/27501068?dopt=Abstract
